Polythiazide/Prazosin Hydrochloride

多噻嗪/盐酸哌唑嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePolythiazide/Prazosin Hydrochloride
Drug Alias Nameprazosin hydrochloride and polythiazidePrazosin Hydrochloride/PolythiazidePolythiazide and Prazosin HydrochlorideMinizide
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAdrenergic receptors
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1980/06/13
Country/TerritoryUnited States
CombinationsYes PolythiazidePrazosin Hydrochloride
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC02LE01
Related LinksN/A